CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine

dc.contributor.author	Cernuda Morollón, Eva María
dc.contributor.author	Martínez Camblor, Pablo
dc.contributor.author	Ramón Carbajo, César
dc.contributor.author	Larrosa Campo, Davinia
dc.contributor.author	Serrano Pertierra, Esther
dc.contributor.author	Pascual Gómez, Julio
dc.date.accessioned	2014-06-11T10:22:45Z
dc.date.available	2014-06-11T10:22:45Z
dc.date.issued	2014
dc.identifier.citation	Headache: The Journal of Head and Face Pain, 54, p. 987-995 (2014); doi:10.1111/head.12372
dc.identifier.issn	1526-4610
dc.identifier.uri	http://hdl.handle.net/10651/27299
dc.description.sponsorship	This study was supported by the PI11/00889 FISSS grant (Fondos Feder, ISCIII, Ministry of Economy, Spain). P.M.C. is supported by grant MTM2011-23204 of the Spanish Ministry of Science and Innovation
dc.format.extent	p. 987-995
dc.language.iso	eng
dc.publisher	Wiley
dc.relation.ispartof	Headache: The Journal of Head and Face Pain
dc.rights	© 2014 Wiley
dc.title	CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine
dc.type	journal article
dc.identifier.local	20141827
dc.identifier.doi	10.1111/head.12372
dc.relation.projectID	MEC-FEDER/PI11/00889 FISSS
dc.relation.projectID	MEC/MTM2011-23204
dc.relation.publisherversion	http://dx.doi.org/10.1111/head.12372

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.